Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/2015 → 30/08/2016 |
Collaborative partners
- King's College London (lead)
- Queen Mary University of London
Combinatory αvβ6 integrin -targeted nanomedicines and immunotherapy for pancreatic cancer therapy
- Al-Jamal, Khuloud (Primary Investigator)
- Maher, John (Co-Investigator)
Project: Research